Dare Bioscience, Inc. — Regulation A 1-A/A
Dare Bioscience, Inc. of SAN DIEGO, CA filed a Regulation A 1-A/A with the SEC on 2025-12-29. Aggregate offering: $24.3M (Tier 2). Industry: Other.
Offering
- Filed: 2025-12-29
- Form: 1-A/A
- Accession: 0001493152-25-029450
- Tier: Tier 2
- Total aggregate offering: $24.3M
- Issuer portion: $24.3M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock), Option, warrant or other right to acquire another security, Security to be acquired upon exercise of option, warrant or other right to acquire security
- Broker-dealer CRD: 000166401
- Audit status: Audited
- Auditor: Haskell & White LLP
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001401914
- Organized in: DE
- Incorporated: 2005
- Address: 3655 NOBEL DRIVE, SAN DIEGO, CA, 92122
- Phone: 858-926-7655
- Employees: 21 full-time, 3 part-time
Financial snapshot (as filed)
- Total assets: $30.7M
- Cash & equivalents: $23.1M
- Total liabilities: $27.9M
- Stockholder equity: $2.9M
- Revenues: $7K
- Net income: $-12.0M
People (1)
| Name | Role | Location |
|---|
| Edwin Astudillo | Signer | SAN DIEGO, CA |
Other Reg A filings by this issuer (2)
More